Cardiac Biomarkers Market
Cardiac Biomarkers Market Analysis by Creatine Kinase, Troponins, Myoglobin, Natriuretic Peptides, and Ischemia Modified Albumin (IMA) from 2023 to 2033
Analysis of Cardiac Biomarkers Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cardiac Biomarkers Market Outlook (2023 to 2033)
A newly published research report by Fact.MR says that the global cardiac biomarkers market stands at US$ 13.37 billion in 2023. Worldwide demand for cardiac biomarkers is projected to accelerate at a CAGR of 11% and reach a market value of US$ 38 billion by 2033.
Rising use of cardiac biomarkers as an integrated diagnostic approach against different cardiovascular diseases, including ischemia modified albumin (IMA), myoglobin, troponin I and T, brain natriuretic peptide (BNPs), myocardial muscle creatine kinase, and others is generating their higher demand.
Cardiac biomarkers are endogenous substances that include proteins, hormones, and enzymes that are released into the blood at the time of some specific cardiovascular conditions. These conditions indicate abnormalities in the functioning of the cardiac system. Healthcare providers are focusing on detecting these specific markers for the identification and diagnosis of critical cardiac conditions, including acute coronary syndrome (ACS), heart attack, etc.
- Worldwide demand for cardiac biomarkers for congestive heart failure is projected to increase at 12.3% CAGR through 2033.
- Siemens AG, F. Hoffmann-La Roche AG, and Abbott are three prominent companies operating globally. They account for around 30% share of the global market revenue.
In recent years, the burden of CVDs (cardiovascular diseases) has been increasing across the globe due to various factors, including diabetes, lifestyle changes, obesity, and smoking. Increasing cases related to heart diseases or disorders are predicted to fuel demand for effective tools for diagnosis, including cardiac biomarkers.
Robust R&D activities related to cardiovascular interventions along with the introduction of novel and more effective devices used for biomarker tests are projected to drive opportunities for players. They are investing to develop new biomarkers for diagnosis, prognosis, and predictive analysis of the disorders related to cardiovascular health.
For instance :
- In July 2019, Siemens received approval from the United States Food and Drug Administration for high-sensitivity troponin I assay. This aided in the diagnosis of myocardial infarction at early stages.
- In September 2019, Abbott received FDA approval for its blood test ARCHITECT STAT High Sensitivity Troponin-I. It is designed for the detection of heart attacks more accurately and quickly. These heart attack diagnostic tests are more effective than conventional tests.
These novel innovations are projected to lead to increased demand for more effective solutions and thus drive market opportunities. However, there are a few biomarkers that require comparatively more time to obtain results. In addition, sometimes these biomarkers also lead to multiple complications, including misdiagnosis.
| Report Attributes | Details |
|---|---|
| Cardiac Biomarkers Market Size (2023) | US$ 13.37 Billion |
| Forecasted Market Value (2033) | US$ 38 Billion |
| Global Market Growth Rate (2023 to 2033) | 11% CAGR |
| Congestive Heart Failure Segment Growth Rate (2023 to 2033) | 12.3% CAGR |
| Extensively Used Cardiac Biomarkers | Troponins |
| Revenue Share of Top 3 Companies (2022) | 30% |
| Key Companies Profiled | Abbott; Siemens Healthineers; Randox Laboratories Ltd.; Life Diagnostics; Creative Diagnostics; Quidel Corporation; F. Hoffmann-La Roche Ltd.; Biomerieux SA; Bio-Rad Laboratories; Danaher Corporation |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is Demand for Cardiac Biomarkers Surging across the World?
“Rising Requirements of Cardiac Biomarkers to Speed Up Treatment Process”
Cardiac biomarkers are significantly used in the early diagnosis of numerous cardiovascular diseases, including heart attack, acute coronary syndrome, heart failure, and myocardial infarction. According to the WHO (World Health Organization), a lot of people around the world are encountering strokes or myocardial infarctions on an annual basis.
Acute coronary syndrome is a common complication faced by patients with coronary heart disease. Various patients need to undergo hospitalization due to the seriousness of the issue. Therefore, the growing incidences of cardiovascular diseases are projected to lead to the rising requirements for early diagnosis to get timely treatment, leading to the rising adoption of technologically advanced cardiac biomarker tests.
“Emerging Markets with Increasing Cases of Heart Issues”
Several emerging markets, including India, provide significant growth opportunities for suppliers of cardiac diagnostic solutions because of the rising population of heart patients. The rising burden of different types of cardiovascular diseases in these countries is due to multiple factors, including high blood pressure, diabetes, obesity, etc., thus creating opportunities for suppliers.
What’s Restraining the Sales Growth of Cardiac Biomarkers?
“Technical Issues Related to Collection and Storage of Samples”
Cardiac biomarkers are extensively used in epidemiology studies to complete the investigation of numerous stages of disorders in human beings. The process requires more careful handling as well as storage of numerous precious biological samples to get detailed information from limited samples.
Strong quality control measures are required for these samples to offer appropriate conditions of storage to avoid data loss. Studies through cardiac biomarkers use archived specimens and are dependent on the specimens’ integrity and manner of collection, process, and storage. Technical issues in sample collection as well as storage are projected to hamper expansion opportunities over the coming decade.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Strategies Adopted by New Manufacturers to Increase their Market Presence?
“Increased R&D Investments for Development of Novel Cardiac Biomarkers”
Start-ups are spending at a significant rate to develop more efficient and novel cardiac biomarkers. Since conventional cardiac biomarkers lack specificity and require more sensitive cardiac biomarker study of the patients, a need arises for more appropriate solutions.
New entrants are spending on R&D activities to develop technologically advanced cardiac biomarkers. These biomarkers come with more advanced facilities to collect and store samples of patients and ensure authentic analysis of the same. Ambulatory surgical centers across developed countries are also projected to drive the business of specialty clinics, thus contributing to biomarker testing market expansion over the coming 10 years.
Country-wise Insights
How is the United States Market Predicted to Perform Over the Forecast Period?
“Presence of Several Prominent Players and Strong Product Portfolio”
The United States is estimated to maintain its dominance across North America in the coming decade. The increasing expenditure on R&D activities related to healthcare facilities is leading to advancements in cardiac biomarkers. In addition, the presence of various prominent players and their strong product portfolios are generating lucrative market opportunities.
What is Propelling the Demand for Cardiac Biomarkers in China and India?
“Introduction of Multiple Technologically Advanced Cardiac Biomarkers”
Markets in China and India are expected to progress at a significant rate during the projected period because of the introduction of various technologically advanced cardiac biomarkers. Moreover, the developing healthcare infrastructure is also leading to increased opportunities for suppliers in India and China.
Which European Country is Considered Highly Profitable for Market Players?
“Growing Incidence of Myocardial Infarction and Acute Coronary Syndrome in the United Kingdom”
Rising cases of myocardial infarction and acute coronary syndrome are leading to the increasing demand for cardiac biomarkers in the United Kingdom and thus widening the horizon for industry players.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
What is Stimulating the Demand for Troponin across Geographies?
“Rising Cases of Acute Coronary Syndrome and Myocardial Infarction”
Based on product, the global market is classified into troponin, creatine kinase (CK), myoglobin, natriuretic peptides, and ischemia modified albumin (IMA). Among these, demand for troponins is predicted to significantly increase because of the growing preference among various end users.
Troponin tests are performed to diagnose acute coronary syndrome, myocardial infarction, and others. The growing prevalence of acute coronary syndrome and myocardial infarction along with growing incidences of heart failures are some prominent factors boosting demand for cardiac biomarkers globally.
Which End-use Application of Cardiac Biomarkers is Highly Popular?
“Increasing Sales of Cardiac Biomarkers for Congestive Heart Failure Diagnosis”
Myocardial infarction, congestive heart failure, acute coronary syndrome (ACS), and atherosclerosis are some prominent applications of cardiac biomarkers. Among these, biomarkers are prominently used for the diagnosis of congestive heart failure. Demand for biomarkers for congestive heart failure is forecasted to accelerate at a CAGR of 12.3% from 2023 to 2033.
Increasing cases of cardiovascular diseases, including atrial fibrillation, along with thriving demand for biomarker tests to detect heart failure at early stages is also boosting the sales of test kits across regions.
Key Market Players
Industry players are investing for numerous purposes such as ensuring quality control of products, maintaining product standards, strengthening their systems adopted for supply chain management, etc.
Key players are investing in product launches, approvals, etc., to expand their product portfolio and market reach. They are concentrating on increasing their revenue share with the development of more innovative designs of products, offering specificity of test results.
For instance :
- In April 2021, F. Hoffmann-La Roche Ltd. announced the launch of its five new applications for its prominent key cardiac biomarkers that were in combination with the company’s Elecsys technology. They work efficiently in managing cardiovascular diseases and thus assist clinicians in the diagnosis of heart attacks and managing heart failures.
- In April 2021, Siemens AG announced that the company got CE Mark approval for Atellica VTLiPatient-side Immunoassay Analyzer, which is a high-sensitivity troponin I test. This device can detect acute myocardial infarction more effectively.
Abbott, Siemens Healthineers, Randox Laboratories Ltd., Life Diagnostics, Creative Diagnostics, Quidel Corporation, F. Hoffmann-La Roche Ltd., Biomerieux SA, Bio-Rad Laboratories, and Danaher Corporation are key players in the cardiac biomarkers market.
Segmentation of Cardiac Biomarkers Industry Research
-
By Product :
- Creatine Kinase
- Troponins
- Myoglobin
- Natriuretic Peptides
- Ischemia Modified Albumin (IMA)
-
By Application :
- Myocardial Infarction
- Acute Coronary Syndrome (ACS)
- Congestive Heart Failure
- Atherosclerosis
-
By Location of Testing :
- Point-of-care Testing
- Laboratory Testing
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
- 6.1. Myocardial Infarction
- 6.2. Acute Coronary Syndrome (ACS)
- 6.3. Congestive Heart Failure
- 6.4. Atherosclerosis
- 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product
- 7.1. Creatine Kinase
- 7.2. Troponins
- 7.3. Myoglobin
- 7.4. Natriuretic Peptides
- 7.5. Ischemia Modified Albumin (IMA)
- 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Location of Testing
- 8.1. Point-of-care Testing
- 8.2. Laboratory Testing
- 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Abbott
- 17.2. Siemens Healthineers
- 17.3. Randox Laboratories Ltd.
- 17.4. Life Diagnostics
- 17.5. Creative Diagnostics
- 17.6. Quidel Corporation
- 17.7. F. Hoffmann-La Roche Ltd.
- 17.8. Biomerieux SA
- 17.9. Bio-Rad Laboratories
- 17.10. Danaher Corporation
- 18. Assumptions And Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 02: Global Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 07: Global Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022
Table 08: Global Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by Location of Testing, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by Location of Testing, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Location of Testing, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 04: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 05: Global Market Share and BPS Analysis by Application, 2023 & 2033
Figure 06: Global Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 07: Global Market Attractiveness Analysis by Application, 2023 to 2033
Figure 08: Global Market Share and BPS Analysis by Product, 2023 & 2033
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Product, 2023 to 2033
Figure 11: Global Market Share and BPS Analysis by Location of Testing, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by Location of Testing, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by Location of Testing, 2023 to 2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033
Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 24: North America Market Share and BPS Analysis by Application, 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 26: North America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 27: North America Market Share and BPS Analysis by Product, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 30: North America Market Share and BPS Analysis by Location of Testing, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by Location of Testing, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by Location of Testing, 2023 to 2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: Latin America Market Share and BPS Analysis by Application, 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 42: Latin America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 43: Latin America Market Share and BPS Analysis by Product, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 45: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 46: Latin America Market Share and BPS Analysis by Location of Testing, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by Location of Testing, 2023 to 2033
Figure 48: Latin America Market Attractiveness Analysis by Location of Testing, 2023 to 2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Europe Market Share and BPS Analysis by Application, 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 58: Europe Market Attractiveness Analysis by Application, 2023 to 2033
Figure 59: Europe Market Share and BPS Analysis by Product, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 61: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 62: Europe Market Share and BPS Analysis by Location of Testing, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by Location of Testing, 2023 to 2033
Figure 64: Europe Market Attractiveness Analysis by Location of Testing, 2023 to 2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 72: East Asia Market Share and BPS Analysis by Application, 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 74: East Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 75: East Asia Market Share and BPS Analysis by Product, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 77: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 78: East Asia Market Share and BPS Analysis by Location of Testing, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by Location of Testing, 2023 to 2033
Figure 80: East Asia Market Attractiveness Analysis by Location of Testing, 2023 to 2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Application, 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Application, 2023 to 2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Location of Testing, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Location of Testing, 2023 to 2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Location of Testing, 2023 to 2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 104: MEA Market Share and BPS Analysis by Application, 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 106: MEA Market Attractiveness Analysis by Application, 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Product, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Product, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Product, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by Location of Testing, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by Location of Testing, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by Location of Testing, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the size of the cardiac biomarkers market in 2023?
The global cardiac biomarkers market stands at US$ 13.37 billion in 2023.
At what rate is the demand for cardiac biomarkers projected to accelerate?
Sales of cardiac biomarkers are projected to increase at a CAGR of 11% from 2023 to 2033.
Which type of cardiac biomarker is gaining traction globally?
Demand for troponins is increasing significantly across the globe.
Which end-use application is most rewarding for industry players?
Sales of cardio biomarkers for congestive heart failure are predicted to advance at a CAGR of 12.3% through 2033.
What was the revenue share of the top 3 three companies in 2022?
Siemens AG, Abbott, and F. Hoffmann-La Roche AG were the top 3 players in 2022 and accounted for around 30% share of the market revenue.
What is the anticipated valuation of the global cardiac biomarkers market for 2033?
The market for cardiac biomarkers is estimated to reach US$ 38 billion by 2033.
Who are the prominent suppliers of cardiac biomarkers operating globally?
Key industry players are Abbott, Siemens Healthineers, Randox Laboratories Ltd., Life Diagnostics, Quidel Corporation, F. Hoffmann-La Roche Ltd., Biomerieux SA, Bio-Rad Laboratories, and Danaher Corporation.
Cardiac Biomarkers Market